148 related articles for article (PubMed ID: 16242632)
21. Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain.
Harigaya Y; Saido TC; Eckman CB; Prada CM; Shoji M; Younkin SG
Biochem Biophys Res Commun; 2000 Sep; 276(2):422-7. PubMed ID: 11027491
[TBL] [Abstract][Full Text] [Related]
22. The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity.
Stege GJ; Renkawek K; Overkamp PS; Verschuure P; van Rijk AF; Reijnen-Aalbers A; Boelens WC; Bosman GJ; de Jong WW
Biochem Biophys Res Commun; 1999 Aug; 262(1):152-6. PubMed ID: 10448084
[TBL] [Abstract][Full Text] [Related]
23. C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.
Trouw LA; Nielsen HM; Minthon L; Londos E; Landberg G; Veerhuis R; Janciauskiene S; Blom AM
Mol Immunol; 2008 Aug; 45(13):3649-60. PubMed ID: 18556068
[TBL] [Abstract][Full Text] [Related]
24. Surface structure of amyloid-beta fibrils contributes to cytotoxicity.
Yoshiike Y; Akagi T; Takashima A
Biochemistry; 2007 Aug; 46(34):9805-12. PubMed ID: 17676931
[TBL] [Abstract][Full Text] [Related]
25. Garlic extract exhibits antiamyloidogenic activity on amyloid-beta fibrillogenesis: relevance to Alzheimer's disease.
Gupta VB; Indi SS; Rao KS
Phytother Res; 2009 Jan; 23(1):111-5. PubMed ID: 18844255
[TBL] [Abstract][Full Text] [Related]
26. High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils.
Olesen OF; Dagø L
Biochem Biophys Res Commun; 2000 Apr; 270(1):62-6. PubMed ID: 10733905
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
[TBL] [Abstract][Full Text] [Related]
28. Alpha-lipoic acid exhibits anti-amyloidogenicity for beta-amyloid fibrils in vitro.
Ono K; Hirohata M; Yamada M
Biochem Biophys Res Commun; 2006 Mar; 341(4):1046-52. PubMed ID: 16460684
[TBL] [Abstract][Full Text] [Related]
29. Catechol derivatives inhibit the fibril formation of amyloid-beta peptides.
Huong VT; Shimanouchi T; Shimauchi N; Yagi H; Umakoshi H; Goto Y; Kuboi R
J Biosci Bioeng; 2010 Jun; 109(6):629-34. PubMed ID: 20471605
[TBL] [Abstract][Full Text] [Related]
30. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
Aisen PS; Saumier D; Briand R; Laurin J; Gervais F; Tremblay P; Garceau D
Neurology; 2006 Nov; 67(10):1757-63. PubMed ID: 17082468
[TBL] [Abstract][Full Text] [Related]
31. Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains.
Welander H; Frånberg J; Graff C; Sundström E; Winblad B; Tjernberg LO
J Neurochem; 2009 Jul; 110(2):697-706. PubMed ID: 19457079
[TBL] [Abstract][Full Text] [Related]
32. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease.
Yang SP; Bae DG; Kang HJ; Gwag BJ; Gho YS; Chae CB
Neurobiol Aging; 2004 Mar; 25(3):283-90. PubMed ID: 15123332
[TBL] [Abstract][Full Text] [Related]
33. Formation of toxic fibrils of Alzheimer's amyloid beta-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component.
Okada T; Wakabayashi M; Ikeda K; Matsuzaki K
J Mol Biol; 2007 Aug; 371(2):481-9. PubMed ID: 17582434
[TBL] [Abstract][Full Text] [Related]
34. Single particle detection of Abeta aggregates associated with Alzheimer's disease.
Funke SA; Birkmann E; Henke F; Görtz P; Lange-Asschenfeldt C; Riesner D; Willbold D
Biochem Biophys Res Commun; 2007 Dec; 364(4):902-7. PubMed ID: 17963690
[TBL] [Abstract][Full Text] [Related]
35. The selective muscarinic M1 agonist AF102B decreases levels of total Abeta in cerebrospinal fluid of patients with Alzheimer's disease.
Nitsch RM; Deng M; Tennis M; Schoenfeld D; Growdon JH
Ann Neurol; 2000 Dec; 48(6):913-8. PubMed ID: 11117548
[TBL] [Abstract][Full Text] [Related]
36. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
37. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.
Dong J; Atwood CS; Anderson VE; Siedlak SL; Smith MA; Perry G; Carey PR
Biochemistry; 2003 Mar; 42(10):2768-73. PubMed ID: 12627941
[TBL] [Abstract][Full Text] [Related]
38. In situ Abeta pores in AD brain are cylindrical assembly of Abeta protofilaments.
Inoue S
Amyloid; 2008 Dec; 15(4):223-33. PubMed ID: 19065293
[TBL] [Abstract][Full Text] [Related]
39. Amyloid-beta aggregation.
Finder VH; Glockshuber R
Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
[TBL] [Abstract][Full Text] [Related]
40. Anti-Parkinsonian agents have anti-amyloidogenic activity for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Neurochem Int; 2006 Mar; 48(4):275-85. PubMed ID: 16343694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
